Mesoblast Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MDXG | MiMedx Group | Buy |
6
|
$7.45 | $11.85 | 67.79% | 1 | $1.08B |
| OFIX | Orthofix Medical | Outperform |
10
|
$14.64 | $18.00 | 36.61% | 2 | $521.27M |
| AXGN | AxoGen | Buy |
6
|
$5.75 | $12.50 | 143.48% | 0 | $256.55M |
| LCTX | Lineage Cell Therapeutics | Outperform |
11
|
$1.17 | $5.40 | 327.35% | 1 | $220.89M |
| CGEN | Compugen | Buy |
7
|
$2.01 | $4.00 | 148.76% | 4 | $170.11M |
| XTNT | Xtant Medical Holdings | Buy |
0
|
$0.81 | $1.93 | 138.27% | 1 | $105.51M |
| PRED | Predictive Technology Group | - |
0
|
$0.00 | $7.00 | 0.00% | 0 | $0.03M |
| CRYO | American CryoStem | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |